This trial is for subjects with multiple myeloma who are eligible for high-dose therapy and autologous stem cell transplantation.
2 Primary · 1 Secondary · Reporting Duration: 100 days
Experimental Treatment
15 Total Participants · 1 Treatment Group
Primary Treatment: Hyperbaric oxygen · No Placebo Group · Phase < 1
Age 18 - 75 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: